The Clorox Company (NYSE:CLX) Holdings Reduced by Tobam

Tobam reduced its stake in shares of The Clorox Company (NYSE:CLX) by 42.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 45,758 shares of the company’s stock after selling 33,319 shares during the period. Clorox makes up about 2.3% of Tobam’s holdings, making the stock its 4th largest holding. Tobam’s holdings in Clorox were worth $7,432,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. State Street Corp grew its stake in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC grew its holdings in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC increased its stake in Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the last quarter. Stifel Financial Corp raised its holdings in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp grew its holdings in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after purchasing an additional 31,510 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.1 %

NYSE:CLX opened at $147.55 on Friday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm has a market cap of $18.26 billion, a PE ratio of 51.41, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a 50-day moving average of $161.83 and a 200 day moving average of $158.67. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the prior year, the firm earned $2.16 EPS. As a group, research analysts anticipate that The Clorox Company will post 6.86 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.31%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.04%.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Finally, Wells Fargo & Company raised their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus target price of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.